Delivery Order SPE2DR25D1002-SPE2DR26FGM9M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units) with a contract ceiling value of $6,576.06. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, classified as a non-set-aside award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,319.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration). This non-set-aside contract is scheduled for completion by January 15, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as the prime contractor and is registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (via its parent company Cencora, Inc.) on January 9, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $11,167.12 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector, 2-pack units, with a ceiling value of $2,277.60 and an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order represents a small-value transaction typical of the company's pharmaceutical supply operations supporting federal medical procurement needs. The...
- The Defense Logistics Agency awarded a $6,832.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, which is scheduled for completion by January 9, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $4,677.22. This is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,300.12 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order is scheduled for completion by January 16, 2026, and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation, reflecting the vendor's proven capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $5,507.40 and a completion date of January 6, 2026. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical supply transaction under the company's broader federal contracting portfolio with DLA. The product will be delivered to AmerisourceBergen's corporate...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM9MDelivery Order
The Defense Logistics Agency awarded a $3,683.32 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 16, 2026, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement typical of the Defense Logistics Agency Medical Supply Chain's ongoing operations. This delivery order is executed under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Amerisourcebergen's role as a critical pharmaceutical distributor positions the company to fulfill essential medical supply requirements across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/14/26 |